Exelixis | 营业费用

Operating Expenses 更改 日
Amgen USD 6.46B 469M 2024-03
AstraZeneca USD 9.54B 578M 2023-09
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Cytokinetics USD 127.07M 2.02M 2024-03
Eli Lilly USD 6.03B 933.2M 2024-03
Exelixis USD 362.93M 126.57M 2024-03
Genmab DKK 3.03B 326M 2023-09
Incyte USD 789.54M 36.54M 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Merck USD 10.02B 6.55B 2024-03
Moderna USD 1.43B 1.37B 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Ultragenyx Pharmaceutical USD 274.18M 24.74M 2024-03



Exelixis 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.